Reference
Lobert, S., et al., Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Biochemistry 35, 6806-6814, (1996)
abstract
Jordan, A., et al., Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Med. Res. Rev. 18, 259-296, (1998)
abstract
Poruchynsky, M.S., et al., Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Cancer Res. 58, 3331-3338, (1998)
abstract
Blagosklonny, M.V., et al., Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Cancer Res. 57, 130-135, (1997)
abstract
Avramis, I.A., et al., Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.
Anticancer Res. 21, 2281-2286, (2001)
abstract
Green, H., et al.
Pharmacol. Toxicol. 93, 297-304, (2003)
abstract
Jong-KeunSon, et al. J. Med. Chem. 33, 1845, (1990)
Horio, M., et al. Proc. Natl. Acad. Sci. USA 85, 3580, (1988)
Renes, J., et al.
Br. J. Pharmacol. 126, 681-688, (1999)
abstract
Murphy, J.A., et al.
Lancet 346, 443, (1995)
abstract
Bohme, A., et al., Ann. Hematol. Transition Metals for Organic Synthesis 71, 311-312, (1995)
Zelcer, N., et al.
J. Biol. Chem. 276, 46400-46407, (2001)
abstract
Mohammad, R.M., et al., Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.
Leuk. Res. 19, 667-673, (1995)
abstract
Merck
Merck 13,10048